[Arg6, D-Trp7,9, NmePhe8]-substance P (6–11) (antagonist G) induces P-1 transcription and sensitizes cells to chemotherapy
2000
[Arg6, D-Trp7,9, NmePhe8]-substance P (6–11) enhances chemotherapy effects in small cell lung cancer
publication
Evidence: moderate
Author Information
Author(s): MacKinnon A C, Waters C, Rahman I, Harani N, Rintoul R, Haslett C, Sethi T
Primary Institution: University of Edinburgh Medical School
Hypothesis
Does antagonist G enhance the effects of chemotherapy in small cell lung cancer?
Conclusion
Antagonist G may improve the effectiveness of chemotherapy in treating small cell lung cancer.
Supporting Evidence
- Antagonist G stimulates JNK activity and apoptosis in SCLC cells.
- Antagonist G increases the activity of the redox-sensitive transcription factor AP-1 by 61%.
- Antagonist G reduces cellular glutathione levels by 38%.
- Antagonist G stimulates ceramide production and lipid peroxidation.
Takeaway
A new substance called antagonist G helps make cancer treatment work better by boosting the effects of chemotherapy.
Methodology
The study involved testing antagonist G's effects on small cell lung cancer cells, focusing on its ability to stimulate JNK activity and apoptosis.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website